AQST CIK: 1398733

Aquestive Therapeutics, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
47.3
FY22:
39.9
FY23:
41.0
FY24:
88.2
FY25:
149
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.7
FY22:
17.2
FY23:
16.5
FY24:
13.2
FY25:
11.2
Total assets
Change from FY21 to FY25
millions USD
FY21:
62.0
FY22:
57.1
FY23:
57.4
FY24:
101
FY25:
160

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
22.0
FY22:
39.5
FY23:
18.3
FY24:
18.9
FY25:
47.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
122
FY22:
136
FY23:
146
FY24:
143
FY25:
146
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.1
FY22:
−119
FY23:
−106
FY24:
−60.2
FY25:
−33.7
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
62.0
FY22:
57.1
FY23:
57.4
FY24:
101
FY25:
160

All amounts in millions USD Data sources:SEC EDGARTwelve Data